home / stock / sera / sera news


SERA News and Press, Sera Prognostics Inc. From 08/10/22

Stock Information

Company Name: Sera Prognostics Inc.
Stock Symbol: SERA
Market: NASDAQ
Website: seraprognostics.com

Menu

SERA SERA Quote SERA Short SERA News SERA Articles SERA Message Board
Get SERA Alerts

News, Short Squeeze, Breakout and More Instantly...

SERA - SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS

SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Aug. 10, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing inn...

SERA - A Negative EV Opportunity - Sera Prognostics Has A Chance To Become Standard Of Care In Preterm Birth Risk Screening

SERA sells PreTRM®, a CLIA-lab based assay to determine the risk of a woman having a pre-term birth – a birth prior to 37 weeks of gestation. After IPO'ing in July 2021 at $16, the Company has since lost over 80% of its value and trades at 50% of its cash and marketable se...

SERA - Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2022 Financial Results on August 10

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2022 Financial Results on August 10 PR Newswire SALT LAKE CITY , July 28, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (Nasdaq: SERA), foc...

SERA - OAS, BRQS and BTCY among mid-day movers

Gainers: Endo International plc (ENDP) +95%. Agile Therapeutics (AGRX) +66%. Kezar Life Sciences (KZR) +53%. Decibel Therapeutics (DBTX) +25%. Ceragon Networks (CRNT) +23%. InflaRx (IFRX) +20%. Sutro Biopharma (STRO) +19%. Tyra Biosciences (TYRA) +17%. Oasis Petroleum (OAS) +16%. Biotricity (...

SERA - SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCE

SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCE PR Newswire SALT LAKE CITY , June 6, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal an...

SERA - SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING IMPROVED PERFORMANCE OF ITS PRETRM® TEST WITH MORE PRECISE GESTATIONAL AGE

SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING IMPROVED PERFORMANCE OF ITS PRETRM® TEST WITH MORE PRECISE GESTATIONAL AGE PR Newswire Results show that the validated proteomics predictor has even greater predictive performance to determine risk of sp...

SERA - SERA PROGNOSTICS PRESENTS DATA DEMONSTRATING THE HEALTH AND ECONOMIC BENEFIT OF PRETRM® TESTING AT ISPOR ANNUAL MEETING

SERA PROGNOSTICS PRESENTS DATA DEMONSTRATING THE HEALTH AND ECONOMIC BENEFIT OF PRETRM® TESTING AT ISPOR ANNUAL MEETING PR Newswire SALT LAKE CITY , May 18, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA...

SERA - Sera Prognostics, Inc. (SERA) CEO Greg Critchfield on Q1 2022 Results - Earnings Call Transcript

Sera Prognostics, Inc. (SERA) Q1 2022 Earnings Conference Call May 10, 2022 17:00 ET Company Participants Peter DeNardo - Investor Relations Greg Critchfield - Chairman, President and Chief Executive Officer Jay Moyes - Chief Financial Officer Conference Call Participants Patrick Donnelly - C...

SERA - Sera Prognostics, Inc. (SERA) Q1 2022 Earnings Call Transcript

Image source: The Motley Fool. Sera Prognostics, Inc. (NASDAQ: SERA) Q1 2022 Earnings Call May 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Sera Prognostics, Inc. (SERA) Q1 2022 Earnings Call Transcript

SERA - Sera Prognostics GAAP EPS of -$0.40 misses by $0.06, revenue of $0.38M beats by $0.31M

Sera Prognostics press release (NASDAQ:SERA): Q1 GAAP EPS of -$0.40 misses by $0.06. Revenue of $0.38M (+192.3% Y/Y) beats by $0.31M. For further details see: Sera Prognostics GAAP EPS of -$0.40 misses by $0.06, revenue of $0.38M beats by $0.31M

Previous 10 Next 10